In a rabbit model, the antagonist sarpogrelate blocks 5-HT2A receptors and may have antiproliferative effects on smooth muscle cells and macrophages by upregulating endothelial nitric oxide synthase (eNOS), thereby delaying the progression of atherosclerosis (65). The gene discussed is NOS3; the disease is atherosclerosis.